Elevation Point Wealth Partners LLC bought a new position in Merck KGaA (OTCMKTS:MKGAF – Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 145,564 shares of the company’s stock, valued at approximately $18,787,000. Elevation Point Wealth Partners LLC owned about 0.11% of Merck KGaA as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors and hedge funds have also recently bought and sold shares of MKGAF. Frazier Financial Advisors LLC purchased a new position in Merck KGaA during the second quarter worth approximately $25,000. Rakuten Securities Inc. acquired a new stake in shares of Merck KGaA during the 2nd quarter worth $27,000. Bard Associates Inc. purchased a new position in shares of Merck KGaA in the 2nd quarter worth $60,000. Kilter Group LLC purchased a new position in shares of Merck KGaA in the 2nd quarter worth $62,000. Finally, Addison Advisors LLC acquired a new position in Merck KGaA in the second quarter valued at $90,000. Institutional investors and hedge funds own 0.10% of the company’s stock.
Merck KGaA Price Performance
MKGAF stock opened at $163.21 on Friday. The stock has a 50-day moving average price of $162.62 and a two-hundred day moving average price of $148.46. Merck KGaA has a 12-month low of $116.68 and a 12-month high of $175.56. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The company has a market cap of $21.09 billion, a PE ratio of 24.92 and a beta of 0.96.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Articles
- Five stocks we like better than Merck KGaA
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
